Valinomycin as an antilipolytic agent. Effects on cyclic 3',5'-adenylic acid, adenyl cyclase, respiration, and glucose metabolism in borwn and white fat cells.
D000225:Adenine / Q000378:metabolism; D000255:Adenosine Triphosphate / Q000378:metabolism; D000262:Adenylyl Cyclases / Q000378:metabolism*; D000273:Adipose Tissue / Q000187:drug effects / Q000378:metabolism; D002001:Adipose Tissue, Brown / Q000187:drug effects / Q000378:metabolism; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002247:Carbon Isotopes; D002852:Chromatography, Ion Exchange; D000242:Cyclic AMP / Q000378:metabolism*; D004837:Epinephrine / Q000378:metabolism; D005230:Fatty Acids, Nonesterified / Q000378:metabolism; D005260:Female; D005947:Glucose / Q000378:metabolism*; D050356:Lipid Metabolism; D010071:Oxaloacetates / Q000494:pharmacology; D010101:Oxygen Consumption / Q000187:drug effects*; D011773:Pyruvates / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D014316:Tritium; D014634:Valinomycin / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D002247:Carbon Isotopes; D005230:Fatty Acids, Nonesterified; D010071:Oxaloacetates; D011773:Pyruvates; D014316:Tritium; D014634:Valinomycin; D000255:Adenosine Triphosphate; D000242:Cyclic AMP; D000262:Adenylyl Cyclases; D005947:Glucose; D000225:Adenine; D004837:Epinephrine